Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone for Prevention of TB-IRIS in High-Risk HIV Patients
NCT01924286Phase 3Completed
- Sponsor
- University of Cape Town
- Start
- Aug 2013
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisone in immune reconstitution inflammatory syndrome (IRIS), sponsored by University of Cape Town. Started Aug 2013; status: completed.
02
Drugs
prednisone
03
Conditions
immune reconstitution inflammatory syndrome (IRIS)
Beyond the preview
Go deeper on NCT01924286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01924286.